Cardiomyopathies

• 

  Subject Areas on Research

  • 2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Management Committee. 
  • A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis. 
  • A Novel Murine Model of Marfan Syndrome Accelerates Aortopathy and Cardiomyopathy. 
  • A case of an infant with flail tricuspid valve due to spontaneous papillary muscle rupture: was neonatal lupus the culprit? 
  • A crisis of the heart: an acute reversible cardiomyopathy bridged to recovery in a patient with Addison's disease. 
  • A fatal case of constrictive pericarditis due to a marked, selective pericardial accumulation of amyloid. 
  • A method to measure myocardial calcium handling in adult Drosophila. 
  • A role for peroxisome proliferator-activated receptor γ coactivator-1 in the control of mitochondrial dynamics during postnatal cardiac growth. 
  • A tale of two diagnoses: The role of noninvasive cardiovascular imaging to differentiate cardiac amyloidosis 
  • ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). 
  • ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. 
  • Abcc9 is required for the transition to oxidative metabolism in the newborn heart. 
  • Ablation of Ventricular Tachycardia Storm With Coronary Venous Ethanol. 
  • Accelerated Marfan syndrome model recapitulates established signaling pathways. 
  • Acute Heart Failure in a 39-Year-Old Man. 
  • Amplatzer vascular plug closure of a subclavian arteriovenous fistula associated with implantable cardioverter-defibrillator implantation. 
  • Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants. 
  • Amylopectinosis disease isolated to the heart with normal glycogen branching enzyme activity and gene sequence. 
  • An N-ethyl-N-nitrosourea mutagenesis recessive screen identifies two candidate regions for murine cardiomyopathy that map to chromosomes 1 and 15. 
  • An association between fetal parvovirus B19 infection and fetal anomalies: a report of two cases. 
  • Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group. 
  • Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. 
  • Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? 
  • Assessment of the 2017 AHA/ACC/HRS Guideline Recommendations for Implantable Cardioverter-Defibrillator Implantation in Cardiac Sarcoidosis. 
  • Atrial fibrillation in heart failure: what should we do? 
  • Atypical and unusual calcifications of the heart and great vessels: imaging findings. 
  • Audible implantable cardioverter defibrillator alarms detect intermittent conductor discontinuity. 
  • Beta-adrenergic axis and heart disease. 
  • Bloodless Orthotopic Heart Transplantation in a Jehovah's Witness. 
  • Both selenium deficiency and modest selenium supplementation lead to myocardial fibrosis in mice via effects on redox-methylation balance. 
  • Burden of medical co-morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy. 
  • CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial. 
  • CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study. 
  • Calcified cardiac lesion. 
  • Can we now find the needle in the haystack? 
  • Cancer Survivorship and Subclinical Myocardial Damage. 
  • Cardiac Dysfunction After Neurologic Injury: What Do We Know and Where Are We Going? 
  • Cardiac Dysfunction Among People Living With HIV: A Systematic Review and Meta-Analysis. 
  • Cardiac MRI for Detection of Cardiac Sarcoidosis. 
  • Cardiac MRI scar patterns differ by sex in an implantable cardioverter-defibrillator and cardiac resynchronization therapy cohort. 
  • Cardiac Magnetic Resonance Scar Imaging for Sudden Cardiac Death Risk Stratification in Patients with Non-Ischemic Cardiomyopathy. 
  • Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C. 
  • Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction. 
  • Cardiac sarcoidosis: two cases with autopsy findings. 
  • Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer. 
  • Cardiomyopathy in Friedreich's Ataxia. 
  • Cardiomyopathy is associated with ribosomal protein gene haplo-insufficiency in Drosophila melanogaster. 
  • Cardiovascular Complications of HIV in Endemic Countries. 
  • Case study: heart transplantation--increased incidence of acute rejection in female recipients. 
  • Cellular and molecular alterations in the beta adrenergic system with cardiomyopathy induced by tachycardia. 
  • Characteristics, Treatments, and Outcomes of Hospitalized Heart Failure Patients Stratified by Etiologies of Cardiomyopathy. 
  • Children with sick hearts: towards anesthesia safety. 
  • Chronic counterpulsation devices for heart failure. 
  • Circulating T-Cell Subsets, Monocytes, and Natural Killer Cells in Peripartum Cardiomyopathy: Results From the Multicenter IPAC Study. 
  • Clinical and imaging manifestations of pediatric sarcoidosis. 
  • Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. 
  • Commentary: Sympathectomy for cardiomyopathy: It's a matter of nerves. 
  • Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. 
  • Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy. 
  • Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells. 
  • Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis. 
  • Comparison of survival among patients with connective tissue disease and cardiomyopathy (systemic sclerosis, systemic lupus erythematosus, and undifferentiated disease). 
  • Comparison of the relation between left ventricular anatomy and QRS duration in patients with cardiomyopathy with versus without left bundle branch block. 
  • Comparison of two-dimensional echocardiographic and angiographic findings in arrhythmogenic right ventricular dysplasia. 
  • Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. 
  • Core lab analysis of baseline echocardiographic studies in the STICH trial and recommendation for use of echocardiography in future clinical trials. 
  • Death during coronary angiography in a woman with cardiac amyloidosis. 
  • Decreased beta-adrenergic responsiveness following hypertrophy occurs only in cardiomyocytes that also re-express beta-myosin heavy chain. 
  • Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. 
  • Deletion of Siah-interacting protein gene in Drosophila causes cardiomyopathy. 
  • Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. 
  • Diabetic cardiomyopathy and carnitine deficiency. 
  • Diabetic retinopathy and risk of heart failure. 
  • Diagnosis of mitochondrial trifunctional protein deficiency in a blood spot from the newborn screening card by tandem mass spectrometry and DNA analysis. 
  • Diagnostic performance of computed tomography angiography for differentiating ischemic vs nonischemic cardiomyopathy. 
  • Diminishment of respiratory sinus arrhythmia foreshadows doxorubicin-induced cardiomyopathy. 
  • Does Survival on the Heart Transplant Waiting List Depend on the Underlying Heart Disease? 
  • Ectopic cardiac calcification associated with hyperparathyroidism in a boy with hypophosphatemic rickets. 
  • Editorial commentary: renal failure after cardiac transplantation: of bravery, wisdom and honesty. 
  • Effect of a purified diet on dystrophic cardiac calcinosis in mice. 
  • Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2). 
  • Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance. 
  • Electrocardiographic findings over time in arrhythmogenic right ventricular dysplasia/cardiomyopathy. 
  • Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected]. 
  • Extracellular space measurements with CMR imaging. 
  • Factors associated with the change in prevalence of cardiomyopathy at delivery in the period 2000-2009: a population-based prevalence study. 
  • Failure of normalized ventricular filling rates to predict true filling rates. 
  • Fatal esorubicin-induced cardiomyopathy: report of a case and review of the literature. 
  • Fundamental concepts in myocardial viability assessment revisited: when knowing how much is "alive" is not enough. 
  • Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis. 
  • Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. 
  • Heart failure in sub-Saharan Africa. 
  • High mortality with severe dystrophic cardiac calcinosis in C3H/OUJ mice fed high fat purified diets. 
  • Highlights of the 2010 scientific sessions of the Heart Failure Society of America, San Diego, California, September 12-15, 2010. 
  • Human cardiac transplantation at the University of Minnesota. 
  • Human pathologic correlation with PET in ischemic and nonischemic cardiomyopathy. 
  • Hydroxychloroquine: a treatable cause of cardiomyopathy. 
  • Hypertension and reversible myocardial depression associated with autologous bone marrow transplantation. 
  • Hyponatremia in pediatric patients with HIV-1 infection. 
  • ICDs Are Still an Effective Therapy to Prevent Sudden Cardiac Death in Heart Failure. 
  • Identifying stunned myocardium during cardiac surgery: the role of myocardial contrast echocardiography. 
  • Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance. 
  • Impact of Cardiovascular Magnetic Resonance Imaging on Identifying the Etiology of Cardiomyopathy in Patients Undergoing Cardiac Transplantation. 
  • Impact of surgical ventricular reconstruction on sphericity index in patients with ischaemic cardiomyopathy: follow-up from the STICH trial. 
  • Impact of valvular calcification on the diagnostic accuracy of transesophageal echocardiography for the detection of congenital aortic valve malformation. 
  • Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block. 
  • Implantable Cardioverter Defibrillators for Nonischemic Cardiomyopathy-Reply. 
  • Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysis. 
  • Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstruction. 
  • Improved outcomes in peripartum cardiomyopathy with contemporary. 
  • Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy. 
  • Incidence and predictors of appropriate therapies delivered by the implantable cardioverter defibrillator in patients with ischemic cardiomyopathy: a systematic review. 
  • Inclusion of Functional Status Measures in the Risk Adjustment of 30-Day Mortality After Transcatheter Aortic Valve Replacement: A Report From the Society of Thoracic Surgeons/American College of Cardiology TVT Registry. 
  • Increased alpha2 subunit-associated AMPK activity and PRKAG2 cardiomyopathy. 
  • Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial. 
  • Infectious complications in extended criteria heart transplantation. 
  • Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. 
  • Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. 
  • Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial. 
  • Invited commentary. 
  • Ipecac myopathy and cardiomyopathy. 
  • Iron overload following red blood cell transfusion and its impact on disease severity. 
  • Isolated mitral valve repair in patients with depressed left ventricular function. 
  • Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring. 
  • Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. 
  • Late gadolinium cardiovascular magnetic resonance in the assessment of myocardial viability. 
  • Left bundle branch block-induced left ventricular remodeling and its potential for reverse remodeling. 
  • Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy. 
  • Lethal Cardiomyopathy in Mice Lacking Transferrin Receptor in the Heart. 
  • Life-threatening congestive heart failure as the presentation of centronuclear myopathy. 
  • Lipomatous hypertrophy of the atrial septum: diagnosis by combined two-dimensional echocardiography and computerized tomography. 
  • Localization of myocardial scar in patients with cardiomyopathy and left bundle branch block using electrocardiographic Selvester QRS scoring. 
  • Long-term follow-up of patients with echocardiographically detected mitral anular calcium and comparison with age- and sex-matched control subjects. 
  • Losartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient mdx mice. 
  • Low lead one ratio predicts clinical outcomes in left bundle branch block. 
  • Management and prevention of cardiovascular hemorrhage associated with mediastinitis. 
  • Management of Ventricular Arrhythmias and Sudden Cardiac Death Risk Related to Ischemic and Nonischemic Cardiomyopathy. 
  • Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic. 
  • Maternal Obesity Affects Cardiac Remodeling and Recovery in Women with Peripartum Cardiomyopathy. 
  • Mechanism and significance of a decrease in ejection fraction during exercise in patients with coronary artery disease and left ventricular dysfunction at rest. 
  • Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial). 
  • Medical screening participation in the childhood cancer survivor study. 
  • Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice. 
  • Meta-analysis of cardiomyopathy-associated variants in troponin genes identifies loci and intragenic hot spots that are associated with worse clinical outcomes. 
  • Metallothionein alleviates glutathione depletion-induced oxidative cardiomyopathy in murine hearts. 
  • Microvascular disease and cardiomyopathy. 
  • Mitochondrial dysfunction in human immunodeficiency virus-1 transgenic mouse cardiac myocytes. 
  • Mitochondrial myopathy with anemia, cardiomyopathy, and lactic acidosis: a distinct late onset mitochondrial disorder. 
  • Mitochondrial quality-control dysregulation in conditional HO-1-/- mice. 
  • Mitral annular calcification and coarctation of aorta. 
  • Mobile intracardiac calcinosis: risk of thromboembolism in patients with haemodialysed end stage renal disease. 
  • Molecular evolution of the junctophilin gene family. 
  • Morphomechanic phenotypic variability of sarcomeric cardiomyopathies: A multifactorial polygenic perspective. 
  • MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet. 
  • Musical murmurs: clinical implications, long-term prognosis, and echo-phonocardiographic features. 
  • Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy. 
  • Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial. 
  • Myocardial Fibrosis and Prognosis in Heart Transplant Recipients. 
  • Myocardial Fibrosis in Duchenne and Becker Muscular Dystrophy-Reply. 
  • Myocardial Involvement in Patients With Histologically Diagnosed Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis of Gross Pathological Images From Autopsy or Cardiac Transplantation Cases. 
  • Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial. 
  • Myocardial bridges: effect of propranolol on systolic compression. 
  • Myocardial scar in sarcoidosis by 12-lead ECG and pathology. 
  • Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: results of the Surgical Treatment for Ischemic Heart Failure trial. 
  • Myocarditis and long-term survival in peripartum cardiomyopathy. 
  • Neonate with coxsackie B1 infection, cardiomyopathy and arrhythmias. 
  • Nonischemic cardiomyopathy associated with autoimmune polyglandular syndrome type II. 
  • Novel--and "neu"--therapeutic possibilities for heart failure. 
  • Outcomes and predictors of recovery in acute-onset cardiomyopathy: A single-center experience of patients undergoing endomyocardial biopsy for new heart failure. 
  • Outcomes following cardioversion for patients with cardiac amyloidosis and atrial fibrillation or atrial flutter. 
  • Paediatric cardiomyopathy and anaesthesia. 
  • Pathophysiology and clinical evaluation of acute heart failure. 
  • Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy. 
  • Peripartum cardiomyopathy presenting as an acute myocardial infarction. 
  • Persistent angina pectoris in ischaemic cardiomyopathy: increased rehospitalization and major adverse cardiac events. 
  • Pheochromocytoma complicated with cardiomyopathy after delivery--a case report and literature review. 
  • Pompe disease in infants: improving the prognosis by newborn screening and early treatment. 
  • Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done? 
  • Premature ventricular contraction-induced cardiomyopathy in children. 
  • Presentation of multicentric Castleman's disease with sicca syndrome, cardiomyopathy, palmar and plantar rash. 
  • Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis. 
  • Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: Diminishing Returns With Advancing Age? 
  • Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Cardiomyopathy. 
  • Prognostic Value of Myocardial Damage in Patients With Sarcoidosis: Is Cardiac Magnetic Resonance What We Need? 
  • Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. 
  • Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: A systematic review. 
  • Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition. 
  • Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's ataxia cardiomyopathy. 
  • Providing primary care for long-term survivors of childhood acute lymphoblastic leukemia. 
  • Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. 
  • QTL mapping in a mouse model of cardiomyopathy reveals an ancestral modifier allele affecting heart function and survival. 
  • Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy. 
  • Recurrence of cardiac sarcoidosis in a heart transplant recipient. 
  • Regional circumferential strain is a biomarker for disease severity in duchenne muscular dystrophy heart disease: a cross-sectional study. 
  • Regional left ventricular function does not predict survival in ischaemic cardiomyopathy after cardiac surgery. 
  • Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study. 
  • Reply: Early Cardiac Resynchronization Therapy for Left Bundle Branch Block-Associated Cardiomyopathies. 
  • Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. 
  • Response to: The paradox of implantable cardioverter-defibrillator: When guidelines play against care improvement. 
  • Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. 
  • Rethinking papillary muscle resection for refractory ventricular tachycardia in the LVAD era. A case report. 
  • Revascularization for Heart Failure: Can We Do Better? 
  • Reversible cardiomyopathies--a review. 
  • Right ventricle-dominant cardiac sarcoidosis with sparing of the left ventricle. 
  • Right, but not left, bundle branch block is associated with large anteroseptal scar. 
  • Right-sided heart catheterization: de rigueur in sarcoidosis? 
  • Role of Mitochondrial Oxidative Stress in Glucose Tolerance, Insulin Resistance, and Cardiac Diastolic Dysfunction. 
  • Sarcoidosis with incomplete bilateral bundle branch block pattern disappearing following steroid therapy: an electrophysiological study. 
  • Shooting at a moving target: natural history studies and the rapidly improving state of anti-HIV treatment. 
  • Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy. 
  • Specificity of electrocardiographic myocardial infarction screening criteria in patients with nonischemic cardiomyopathies. 
  • Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). 
  • Stunned myocardium in the toxic shock syndrome. 
  • Summarizing polygenic risks for complex diseases in a clinical whole-genome report. 
  • Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials. 
  • Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. 
  • TASK-1 and TASK-3 channels modulate pressure overload-induced cardiac remodeling and dysfunction. 
  • Takotsubo cardiomyopathy: an unusual syndrome mimicking an ST-elevation myocardial infarction. 
  • The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. 
  • The Causes of HIV-Associated Cardiomyopathy: A Tale of Two Worlds. 
  • The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. 
  • The Prevalence, Correlates, and Impact on Cardiac Mortality of Right Ventricular Dysfunction in Nonischemic Cardiomyopathy. 
  • The authors reply. 
  • The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment. 
  • The cardiac vulnerable period and reentrant arrhythmias: targets of anti- and proarrhythmic processes. 
  • The case of the disappearing myxoma. 
  • The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). 
  • The junctophilin family of proteins: from bench to bedside. 
  • The radiographic distinction between pericardial and myocardial calcifications. 
  • The role of cardiac MR in new-onset heart failure. 
  • The role of cardiovascular MRI in heart failure and the cardiomyopathies. 
  • Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy. 
  • Thoracic sarcoidosis: radiologic-pathologic correlation. 
  • Three-dimensional echocardiographic measurement of left ventricular mass: comparison with magnetic resonance imaging and two-dimensional echocardiographic determinations in man. 
  • Time dependence of arrhythmias in ICD patients. 
  • Tnni3k modifies disease progression in murine models of cardiomyopathy. 
  • Transcatheter aortic valve replacement performed via left ventricular assist device inflow cannula. 
  • Transcriptomic biomarkers for the accurate diagnosis of myocarditis. 
  • Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. 
  • Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial. 
  • Two-dimensional echocardiography in arrhythmogenic right ventricular dysplasia. 
  • Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. 
  • Understanding and recognizing cardiac amyloidosis. 
  • Unexpected Cardiac MRI Findings in Patients Presenting to the Emergency Department for Possible Acute Coronary Syndrome. 
  • Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy. 
  • Use of coronary angiography and revascularization after acute myocardial infarction. 
  • Validation of a novel modified wall motion score for estimation of left ventricular ejection fraction in ischemic and non-ischemic cardiomyopathy. 
  • Validation of sub-segmental visual scoring for the quantification of ischemic and nonischemic myocardial fibrosis using late gadolinium enhancement MRI. 
  • Value of Cardiovascular Magnetic Resonance Imaging-Derived Baseline Left Ventricular Ejection Fraction and Volumes for Precise Risk Stratification of Patients With Ischemic Cardiomyopathy: Insights From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial. 
  • Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy. 
  • Widely disseminated Cunninghamella mucormycosis in an adult renal transplant patient: case report and review of the literature. 
• 

  Keywords of People

  • Barker, Piers Christopher Andrew, Professor of Pediatrics, Pediatrics, Cardiology
  • Bursac, Nenad, Professor of Biomedical Engineering, Biomedical Engineering
  • Carboni, Michael Paul, Associate Professor of Pediatrics, Pediatrics, Cardiology
  • Farzaneh-Far, Afshin, Assistant Consulting Professor in the Department of Medicine, Medicine, Cardiology
  • Mentz, Robert John, Associate Professor of Medicine, Medicine, Cardiology
  • Milano, Carmelo Alessio, Professor of Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Milazzo Jr., Angelo Stephen, Professor of Pediatrics, Pediatrics
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology
  • Swaminathan, Madhav, Professor of Anesthesiology, Anesthesiology, Cardiothoracic